β-globin restored autologous hsc
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2020 (NCT04211480)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04592458 | Phase 1 | Nov 1, 2020 | BGI Group, Shenzhen University |
| NCT04211480 | N/A | Mar 1, 2020 | Central South University, Shanghai Bioray Laboratory Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BGI Group | For profit | 1 | 1 | 1 | 2020 |
| Central South University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Shanghai Bioray Laboratory Inc. | For profit | 1 | 1 | 1 | 2020 |
| Shenzhen University | Academic/Hospital | 1 | 0 | 1 | 2020 |
4 organizations
Page 1 / 1